Topics

Galcanezumab Cuts Frequency of Disabling Cluster Headaches

06:40 EDT 12 Jul 2019 | Medscape

Galcanezumab is a welcome option for patients who have grown frustrated with currently available treatment options, one headache expert said.
Medscape Medical News

Original Article: Galcanezumab Cuts Frequency of Disabling Cluster Headaches

NEXT ARTICLE

More From BioPortfolio on "Galcanezumab Cuts Frequency of Disabling Cluster Headaches"

Quick Search